US Stock MarketDetailed Quotes

CMMB Chemomab Therapeutics

Watchlist
  • 0.880
  • +0.066+8.11%
Close May 14 16:00 ET
  • 0.890
  • +0.010+1.14%
Pre 08:25 ET
12.51MMarket Cap-571P/E (TTM)

Chemomab Therapeutics Key Stats

Chemomab Therapeutics Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings

May 9, 2024

Revenue(YoY)

0.00

0.00%
EPS(YoY)

-0.28

+65.00%

Buy

May 13, 2024

Chemomab Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q2-- / 0.000--
May 9, 20242024/Q1-- / 0.000--
Mar 7, 20242023/Q40.000 / 0.000--
Nov 9, 20232023/Q30.000 / 0.000--
--2023/Q20.000 / 0.000--
May 11, 20232023/Q10.000 / 0.000--
--2022/Q40.000 / 0.000--
Nov 11, 20222022/Q30.000 / 0.000--
Aug 12, 20222022/Q20.000 / 0.000--
May 12, 20222022/Q10.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q2-- / 0.000--
May 9, 20242024/Q1-- / 0.000--
Mar 7, 20242023/Q40.000 / 0.000--
Nov 9, 20232023/Q30.000 / 0.000--
--2023/Q20.000 / 0.000--
May 11, 20232023/Q10.000 / 0.000--
--2022/Q40.000 / 0.000--
Nov 11, 20222022/Q30.000 / 0.000--
Aug 12, 20222022/Q20.000 / 0.000--
May 12, 20222022/Q10.000 / 0.000--

Unlock Free Earnings Estimates

Chemomab Therapeutics Earnings Reports

Read more

Analysis

Analyst Rating

Updated: May 13, 2024

Buy

  • Buy

    100.00%
  • Hold

    0.00%
  • Sell

    0.00%

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg